Tuberculous meningitis

Acta Neurologica Scandinavica

Volumn 122, Issue 2, 2010, Pages 75-90

  Garg, R K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Bacillus Calmette Gu rin vaccination; dexamethasone; extrapulmonary tuberculosis; human immunodeficiency virus; Mycobacterium tuberculosis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOSALICYLIC ACID; BCG VACCINE; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; GATIFLOXACIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

BACTERIUM CULTURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL TRIAL; EXPERIMENTAL MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNOPATHOGENESIS; LUNG TUBERCULOSIS; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROIMAGING; NEUROSURGERY; NONHUMAN; PATHOGENESIS; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REVIEW; TUBERCULOUS MENINGITIS; UNSPECIFIED SIDE EFFECT; VASCULITIS; VISUAL IMPAIRMENT; VOMITING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTITUBERCULAR AGENTS; BCG VACCINE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; HUMANS; INCIDENCE; SURVIVAL RATE; TUBERCULOSIS, MENINGEAL;

EID: 77953322412     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01316.x     Document Type: Review

References (120)

1. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009 59 : 167 187.
2. Jubelt B. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. Curr Neurol Neurosci Rep 2006 6 : 451 452.
3. Be NA, Kim KS, Bishai WR, Jain SK. Pathogenesis of central nervous system tuberculosis. Curr Mol Med 2009 9 : 94 9.
4. World Health Organization. Global tuberculosis control - surveillance, planning, financing. WHO Report 2009, WHO/HTM/TB/2009.411. Available at: http://www.who.int/tb/publications/global-report/2009/key-points/en/index.html.
5. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL. Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 2008 31 : 99 105.
6. Cailhol J, Che D, Jarlier V, Decludt B, Robert J. Incidence of tuberculous meningitis in France, 2000: a capture-recapture analysis. Int J Tuberc Lung Dis 2005 9 : 803 808.
7. Porkert MT, Sotir M, Parrott-Moore P, Blumberg HM. Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 1997 313 : 325 331.
8. Datta M, Swaminathan S. Global aspects of tuberculosis in children. Paediatr Respir Rev 2001 2 : 91 6.
9. Berman S, Kibel MA, Fourie PB, Strebel PM. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa. Tuber Lung Dis 1992 73 : 349 355.
10. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis 2006 10 : 732 738.
11. Ghate M, Deshpande S, Tripathy S et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis 2009 13 : e1 8.
12. Berenguer J, Moreno S, Laguna F et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992 326 : 668 672.
13. Byrd TF, Davis LE. Multidrug-resistant tuberculous meningitis. Curr Neurol Neurosci Rep 2007 7 : 470 475.
14. Patel VB, Padayatchi N, Bhigjee AI et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004 38 : 851 856.
15. Caws M, Thwaites GE, Duy PM et al. Molecular analysis of Mycobacterium tuberculosis causing multidrug-resistant tuberculosis meningitis. Int J Tuberc Lung Dis 2007 11 : 202 208.
16. Nagarathna S, Rafi W, Veenakumari HB, Mani R, Satishchandra P, Chandramuki A. Drug susceptibility profiling of tuberculous meningitis. Int J Tuberc Lung Dis 2008 12 : 105 107.
17. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J 1999 75 : 133 140.
18. Rich AR, McCordick HA. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hospital 1933 52 : 5 37.
19. Donald PR, Schaaf HS, Schoeman JF. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect 2005 50 : 193 195.
20. Garcia-Monco JC. Central nervous system tuberculosis. Neurol Clin 1999 17 : 737 759.
21. Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008 4 : e1000034.
22. Thwaites G, Caws M, Chau TT et al. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol 2008 46 : 1363 1368.
23. Caws M, Thwaites G, Stepniewska K et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006 44 : 3934 3939.
24. Porcelli SA, Jacobs WR Jr. Tuberculosis: unsealing the apoptotic envelope. Nat Immunol 2008 9 : 1101 1102.
25. Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J 2009 50 : 1 11.
26. Rocha-Ramírez LM, Estrada-García I, López- Marín LM et al. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb) 2008 88 : 212 220.
27. Britton WJ, Fernando SL, Saunders BM, Sluyter R, Wiley JS. The genetic control of susceptibility to Mycobacterium tuberculosis. Novartis Found Symp 2007 281 : 79 89.
28. Fernando SL, Saunders BM, Sluyter R et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med 2007 175 : 360 366.
29. Hawn TR, Dunstan SJ, Thwaites GE et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 2006 194 : 1127 1134.
30. Thuong NT, Hawn TR, Thwaites GE et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007 8 : 422 428.
31. Sallakci N, Coskun M, Berber Z et al. Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis (Edinb) 2007 87 : 225 230.
32. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA 1999 96 : 5657 5662.
33. Rock RB, Hu S, Gekker G et al. Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis 2005 192 : 2054 2058.
34. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008 21 : 243 261.
35. Nagesh Babu G, Kumar A, Kalita J, Misra UK. Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neurosci Lett 2008 436 : 48 51.
36. Simmons CP, Thwaites GE, Quyen NT et al. Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol 2006 176 : 2007 2014.
37. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998 177 : 1563 1572.
38. van Well GT, Wieland CW, Florquin S, Roord JJ, van der Poll T, van Furth AM. A new murine model to study the pathogenesis of tuberculous meningitis. J Infect Dis 2007 195 : 694 697.
39. Be NA, Lamichhane G, Grosset J et al. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. J Infect Dis 2008 198 : 1520 1528.
40. Molavi A, LeFrock JL. Tuberculous meningitis. Med Clin North Am 1985 69 : 315 331.
41. van Well GT, Paes BF, Terwee CB et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 2009 123 : e1 8.
42. Hosolu S, Ayaz C, Geyik MF, Kökolu OF, Ceviz A. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis 1998 2 : 553 557.
43. Srikanth SG, Taly AB, Nagarajan K, Jayakumar PN, Patil S. Clinicoradiological features of tuberculous meningitis in patients over 50 years of age. J Neurol Neurosurg Psychiatry 2007 78 : 536 538.
44. Patwari AK, Aneja S, Ravi RN, Singhal PK, Arora SK. Convulsions in tuberculous meningitis. J Trop Pediatr 1996 42 : 91 7.
45. Hanna LS, Girgis NI, Abu el Ella AH, Farid Z. Ocular complications in meningitis: "fifteen years study". Metab Pediatr Syst Ophthalmol 1988 11 : 160 162.
46. Amitava AK, Alarm S, Hussain R. Neuro-ophthalmic features in pediatric tubercular meningoencephalitis. J Pediatr Ophthalmol Strabismus 2001 38 : 229 234.
47. Lamba PA, Bhalla JS, Mullick DN. Ocular manifestations of tubercular meningitis: a clinico-biochemical study. J Pediatr Ophthalmol Strabismus 1986 23 : 123 125.
48. Akhaddar A, El Hassani MY, Chakir N, Jiddane M. Optochiasmatic tuberculoma: complication of tuberculous meningitis. Report of a case and review of the literature. J Neuroradiol 2001 28 : 137 142.
49. Alarcón F, Dueñas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord 2000 15 : 561 569.
50. Hernández-Albújar S, Arribas JR, Royo A, González-García JJ, Peña JM, Vázquez JJ. Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 2000 30 : 915 921.
51. Wadia NH. Radiculomyelopathy associated with spinal meningitis (arachnoiditis) with special reference to the spinal tuberculous variety. In : Spillane JD, ed. Tropical Neurology.
52. Chan KH, Cheung RT, Lee R, Mak W, Ho SL. Cerebral infarcts complicating tuberculous meningitis. Cerebrovasc Dis 2005 19 : 391 395.
53. Hsieh FY, Chia LG, Shen WC. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992 34 : 197 199.
54. Koh SB, Kim BJ, Park MH, Yu SW, Park KW, Lee DH. Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. J Clin Neurosci 2007 14 : 1073 1077.
55. Andronikou S, Wilmshurst J, Hatherill M, VanToorn R. Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6 months. Pediatr Radiol 2006 36 : 1289 1294.
56. Biswas J, Shome D. Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction of aqueous humor. A case report and review of the literature. Ocul Immunol Inflamm 2002 10 : 293 298.
57. Thompson MJ, Albert DM. Ocular tuberculosis. Arch Ophthalmol 2005 123 : 844 849.
58. Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol 1993 38 : 229 256.
59. Torok ME, Chau TT, Mai PP et al. Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS ONE 2008 3 : e1772.
60. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004 42 : 378 379.
61. Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D. Use of BACTEC MGIT 960 for recovery of Mycobacteria from clinical specimens: multicenter study. J Clin Microbiol 1999 37 : 3578 3582.
62. Caws M, Dang TM, Torok E et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS ONE 2007 2 : e1173.
63. Desai D, Nataraj G, Kulkarni S et al. Utility of the polymerase chain reaction in the diagnosis of tuberculous meningitis. Res Microbiol 2006 157 : 967 970. (Pubitemid 44828461)
64. Rafi W, Venkataswamy MM, Nagarathna S, Satishchandra P, Chandramuki A. Role of IS6110 uniplex PCR in the diagnosis of tuberculous meningitis: experience at a tertiary neurocentre. Int J Tuberc Lung Dis 2007 11 : 209 214.
65. Pai M, Flores LL, Hubbard A et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003 3 : 633 643.
66. Haldar S, Sharma N, Gupta VK, Tyagi JS. Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR. J Med Microbiol 2009 58 : 616 624.
67. Pai M, Ling DI. Rapid diagnosis of extrapulmonary tuberculosis using nucleic acid amplification tests: what is the evidence? Future Microbiol 2008 3 : 1 4.
68. Desai MM, Pal RB. Polymerase chain reaction for the rapid diagnosis of tuberculous meningitis. Indian J Med Sci 2002 56 : 546 552.
69. Thwaites GE, Caws M, Chau TT et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004 42 : 996 1002.
70. Thomas MM, Hinks TS, Raghuraman S et al. Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int J Tuberc Lung Dis 2008 12 : 651 657.
71. Chen X, Yang Q, Zhang M et al. Diagnosis of active tuberculosis in china using an in-house interferon-gamma enzyme-linked immunospot assay. Clin Vaccine Immunol 2009 16 : 879 884.
72. Quan C, Lu CZ, Qiao J, Xiao BG, Li X. Comparative evaluation of early diagnosis of tuberculous meningitis by different assays. J Clin Microbiol 2006 44 : 3160 3166.
73. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 2004 34 : 876 885.
74. Ozates M, Kemaloglu S, Gurkan F, Ozkan U, Hosoglu S, Simsek MM. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol 2000 41 : 13 7.
75. Chan KH, Cheung RT, Fong CY, Tsang KL, Mak W, Ho SL. Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis. QJM 2003 96 : 643 648.
76. Andronikou S, Wieselthaler N, Smith B et al. Value of early follow-up CT in paediatric tuberculous meningitis. Pediatr Radiol 2005 35 : 1092 1099.
77. Gupta RK, Gupta S, Singh D, Sharma B, Kohli A, Gujral RB. MR imaging and angiography in tuberculous meningitis. Neuroradiology 1994 36 : 87 92.
78. Oztoprak I, Gümüs C, Oztoprak B, Engin A. Contrast medium-enhanced MRI findings and changes over time in stage I tuberculous meningitis. Clin Radiol 2007 62 : 1206 1215.
79. Yaramis A, Bükte Y, Katar S, Ozbek MN. Chest computerized tomography scans findings in 74 children with tuberculous meningitis in southeastern Turkey. Turk J Pediatr 2007 49 : 365 369.
80. Thwaites GE, Chau TT, Stepniewska K et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002 360 : 1287 1292.
81. Youssef FG, Afifi SA, Azab AM et al. Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters. Diagn Microbiol Infect Dis 2006 55 : 275 278.
82. Chamberlain MC. Neoplastic meningitis. Curr Neurol Neurosci Rep 2008 8 : 249 258.
83. Aparicio A, Chamberlain MC. Neoplastic meningitis. Curr Neurol Neurosci Rep 2002 2 : 225 235.
84. Thwaites GE, Duc Bang N, Huy Dung N et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005 192 : 2134 2141.
85. Dubé MP, Holtom PD, Larsen RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992 93 : 520 524.
86. van der Weert EM, Hartgers NM, Schaaf HS et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2006 25 : 65 9.
87. Cecchini D, Ambrosioni J, Brezzo C et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 2009 13 : 269 271.
88. Cecchini D, Ambrosioni J, Brezzo C et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS 2007 21 : 373 374.
89. Ziganshina LE, Squire SB. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 2008 Art. No.: CD004795. DOI:.
90. Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 2007 67 : 2077 2099.
91. Kaojarern S, Supmonchai K, Phuapradit P, Mokkhavesa C, Krittiyanunt S. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther 1991 49 : 6 12.
92. World Health Organization. Treatment of tuberculosis: guidelines for national programmes, 3rd edn.
93. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003 167 : 603 662.
94. Pepper DJ, Marais S, Maartens G et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009 48 : e96 107.
95. Huttner HB, Kollmar R, Hug A, Meisel F, Kress B, Schwab S. Fatal tuberculous meningitis caused by immune restoration disease. J Neurol 2004 251 : 1522 1523.
96. McIlleron H, Meintjes G, Burman WJ, Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007 196 (Suppl 1 S63 75.
97. Saukkonen JJ, Cohn DL, Jasmer RM et al. ATS (American Thoracic Society) hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006 174 : 935 952.
98. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008 Art. No.: CD002244. DOI:.
99. Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004 351 : 1741 1751.
100. Thwaites GE, Macmullen-Price J, Tran TH et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007 6 : 230 236.
101. Simmons CP, Thwaites GE, Quyen NT et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 2005 175 : 579 590.
102. Green JA, Tran CT, Farrar JJ et al. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS ONE 2009 4 : e7277.
103. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994 19 : 1092 1099.
104. Garcia-Monco JC, Ferreira E, Gomez-Beldarrain M. The therapeutic paradox in the diagnosis of tuberculous meningitis. Neurology 2005 65 : 1991 1992.
105. Lee SI, Park JH, Kim JH. Paradoxical progression of intracranial tuberculomas and anterior cerebral artery infarction. Neurology 2008 71 : 68.
106. Nicolls DJ, King M, Holland D, Bala J, del Rio C. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005 5 : 795 801.
107. Lamprecht D, Schoeman J, Donald P, Hartzenberg H. Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg 2001 15 : 119 125.
108. Palur R, Rajshekhar V, Chandy MJ, Joseph T, Abraham J. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg 1991 74 : 64 9.
109. Kemaloglu S, Ozkan U, Bukte Y, Ceviz A, Ozates M. Timing of shunt surgery in childhood tuberculous meningitis with hydrocephalus. Pediatr Neurosurg 2002 37 : 194 198.
110. Jha DK, Mishra V, Choudhary A et al. Factors affecting the outcome of neuroendoscopy in patients with tuberculous meningitis hydrocephalus: a preliminary study. Surg Neurol 2007 68 : 35 41.
111. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005 4 : 160 170.
112. Sutlas PN, Unal A, Forta H, Senol S, Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection 2003 31 : 387 391.
113. Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet 1948 I : 582 596.
114. Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician 2005 72 : 1761 1768.
115. Karande S, Gupta V, Kulkarni M, Joshi A. Prognostic clinical variables in childhood tuberculous meningitis: an experience from Mumbai, India. Neurol India 2005 53 : 191 195.
116. Hosoglu S, Geyik MF, Balik I et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002 6 : 64 70.
117. Kalita J, Misra UK, Ranjan P. Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol 2007 14 : 33 7 (Erratum in: Eur J Neurol 2007;14:357).
118. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006 367 : 1173 1180.
119. Kumar R, Dwivedi A, Kumar P, Kohli N. Tuberculous meningitis in BCG vaccinated and unvaccinated children. J Neurol Neurosurg Psychiatry 2005 76 : 1550 1554.
120. Sterling TR, Martire T, de Almeida AS et al. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics 2007 120 : e912 21.